Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_assertion type Assertion NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_head.
- NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_assertion description "[This study aimed to evaluate whether co-expression of interleukin-3 (IL-3) could enhance the anti-tumor activity of HSV-sr39tk/GCV prodrug gene therapy using a murine TRAMP-C1 prostate tumor model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_provenance.
- NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_assertion evidence source_evidence_literature NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_provenance.
- NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_assertion SIO_000772 23441198 NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_provenance.
- NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_assertion wasDerivedFrom befree-20140225 NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_provenance.
- NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_assertion wasGeneratedBy ECO_0000203 NP776310.RAItbXI2-oiV9_wtzN_J79oCrQ6mVT5x_FmMV8YOtdSI0130_provenance.